Carisma Therapeutics, Inc. - Common Stock (CARM)

About Carisma Therapeutics, Inc. - Common Stock (CARM)

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Carisma Therapeutics, Inc. - Common Stock News